| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 126.56B | 121.46B | 117.32B | 114.97B | 109.50B | 108.21B |
| Gross Profit | 25.92B | 25.10B | 23.22B | 23.92B | 23.95B | 22.17B |
| EBITDA | 16.61B | 15.91B | 14.14B | 15.23B | 15.38B | 13.57B |
| Net Income | 10.36B | 9.92B | 8.18B | 9.49B | 8.93B | 8.64B |
Balance Sheet | ||||||
| Total Assets | 115.03B | 122.21B | 124.45B | 122.92B | 115.89B | 112.61B |
| Cash, Cash Equivalents and Short-Term Investments | 25.31B | 30.95B | 34.93B | 30.61B | 32.02B | 30.26B |
| Total Debt | 1.69B | 1.66B | 1.55B | 1.83B | 882.00M | 830.00M |
| Total Liabilities | 29.75B | 33.53B | 33.35B | 37.48B | 35.06B | 36.69B |
| Stockholders Equity | 84.47B | 87.83B | 90.19B | 84.50B | 80.74B | 75.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.63B | 10.59B | 1.81B | 5.63B | 12.01B |
| Operating Cash Flow | 0.00 | 10.35B | 14.59B | 4.76B | 8.60B | 15.21B |
| Investing Cash Flow | 0.00 | -1.90B | -4.25B | 487.00M | -2.35B | -7.23B |
| Financing Cash Flow | 0.00 | -12.40B | -5.33B | -5.76B | -4.69B | -2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥144.47B | 9.06 | ― | 3.22% | 12.23% | 43.29% | |
76 Outperform | ¥191.41B | 10.32 | ― | 3.44% | 11.25% | 36.92% | |
75 Outperform | ¥131.78B | 8.40 | ― | 3.13% | 5.39% | 33.02% | |
71 Outperform | ¥183.39B | 9.99 | ― | 2.87% | 6.66% | 46.38% | |
70 Outperform | ¥124.89B | 9.59 | ― | 1.55% | 20.44% | 106.45% | |
68 Neutral | ¥154.73B | 9.00 | ― | 2.89% | 20.38% | 128.85% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |